Nevertheless, it is important to acknowledge that the Triton WR-1339-induced hyperlipidemia model, although well-established and commonly employed in preclinical studies, induces lipid abnormalities acutely by inhibiting lipoprotein lipase. Here, LPL is linked to hyperlipidemia.